Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.
about
Targeting mitochondrial dysfunction in lung diseases: emphasis on mitophagyPharmacotherapy for pulmonary hypertensionHydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn.B-type natriuretic peptide: prognostic marker in congenital diaphragmatic herniaNew Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications.Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertensionTherapeutic approaches using nitric oxide in infants and children.Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newbornCyclic stretch stimulates mitochondrial reactive oxygen species and Nox4 signaling in pulmonary artery smooth muscle cells.Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells.Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn.Developmental differences in hyperoxia-induced oxidative stress and cellular responses in the murine lung.Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn.Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.Role of reactive oxygen species in neonatal pulmonary vascular disease.SOD2 activity is not impacted by hyperoxia in murine neonatal pulmonary artery smooth muscle cells and mice.Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn.Icariside II, a novel phosphodiesterase 5 inhibitor, protects against H2 O2 -induced PC12 cells death by inhibiting mitochondria-mediated autophagyIsolation of pulmonary artery smooth muscle cells from neonatal mice.Diagnosis and treatment of pulmonary hypertension in infancy.Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn.Beyond pulmonary hypertension: sildenafil for chronic lung disease of prematurity.Endothelial Cell Reactive Oxygen Species and Ca2+ Signaling in Pulmonary Hypertension.Redox Signaling and Persistent Pulmonary Hypertension of the Newborn.Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia.Domain Mapping of Heat Shock Protein 70 Reveals That Glutamic Acid 446 and Arginine 447 Are Critical for Regulating Superoxide Dismutase 2 Function.Sex-dependent changes in the pulmonary vasoconstriction potential of newborn rats following short-term oxygen exposure.Signaling molecules in the fetal rabbit model for congenital diaphragmatic hernia.Antenatal hypoxia and pulmonary vascular function and remodeling.L-citrulline supplementation in the treatment of pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infant: A case report.Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheepPulmonary Hypertension Is a Probable NO/ONOO− Cycle Disease: A Review
P2860
Q26992144-19C66480-53B6-4D4B-BBDE-38EB770050D9Q27022763-16FCF202-71E6-4B9D-B6C6-C812584D1360Q33805971-7552E16D-940E-4983-8489-D6CF81EE02D0Q34516884-B1EA3BCE-ED90-423D-A935-FB435072CCA5Q34532327-91E6E585-C684-44E6-9041-BCB8D56351B8Q34627552-93AB01C4-DFEF-4815-A5B6-D5CD3BD7C9D5Q35165230-9CD11984-F58D-4765-81A8-26EB35D2FBABQ35850312-22330D81-A5A2-4744-96B3-4C13B24A9A44Q35850324-646DE7C3-E48B-4B55-9105-9E96B8005FD5Q35859312-7B645F65-7DC7-496B-A5EC-3B2092347B5EQ36001831-B96C86ED-7D96-4578-8F7A-A2A3E0464DF8Q36454374-91911FD2-733B-4A86-B1C6-031C2E1792F0Q37045966-F9DE9EEE-9A97-46D9-9ADD-069431F3E9A7Q37112135-5F3598D1-7E64-4B81-BC30-51548203015AQ37893072-F9CA1013-711F-4207-9A5E-AF136BB2EE9BQ37985076-5B9B99B9-C42D-4ABD-AFA3-FFB9394F7313Q38172267-A542833C-9FE3-4C8F-B1E5-BCAB2C3F8081Q39556769-3A02A587-4981-4341-B288-F3548EBC1B5FQ39663088-6CB6915E-8A79-47A1-9C0E-109BEF7094F8Q41972250-FF9DA185-DE48-4482-B096-B30679710649Q42000773-C64AD024-DE40-4CF0-A3CD-A4B71124A1ACQ42508912-581A1F56-7196-4275-B0A5-BD0EE3F45B16Q43182905-5B6A965E-353E-4C4D-84AE-089C66526505Q44062958-8DF34A77-CF52-447E-95FB-D777AE7CAAD8Q46280838-B4AF151F-5967-44D7-8C0D-C843736E987DQ46280851-D4A2EB5E-94D7-414E-A3D2-C9D75AC14CADQ46280855-01B9989B-450D-417A-A019-B9B870DCEBDAQ48279014-F02109BA-31EB-4166-A506-2A2FAC234CA1Q49814595-8162579C-3B71-454B-A100-E9628A5EE608Q51315297-DFC7131B-30BA-4B99-AABF-610C1F503E06Q51815503-F1BD7DD4-864F-47D9-BC37-ACDB96224D26Q55110701-D9C475A7-4064-4F23-B971-DA78CBF965FDQ55182839-677CC13E-FD22-423C-B92B-1C9B381AE977Q57817366-EBFC549C-381F-4755-A326-B060F6669E12Q58998388-3000AC20-0160-4650-84F7-03C6D2BE02A9
P2860
Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@ast
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@en
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@nl
type
label
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@ast
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@en
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@nl
prefLabel
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@ast
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@en
Mitochondrial oxidant stress i ...... y hypertension of the newborn.
@nl
P2093
P2860
P50
P1476
Mitochondrial oxidant stress i ...... ry hypertension of the newborn
@en
P2093
Keng Jin Lee
Lyubov Czech
Paul T Schumacker
Stephen Wedgwood
Sylvia F Gugino
P2860
P304
P356
10.1016/J.RESP.2010.08.018
P577
2010-09-06T00:00:00Z